« Back to Record
Citation APA

Delforge, M., Selleslag, D., Beguin, Y., Triffet, A., Mineur, P., Theunissen, K., Graux, C., André, M., Trullemans, F., Boulet, D., Van Eygen, K., Noens, L., Van Steenweghen, S., Lemmens, J., Pierre, P., D'hondt, R., Ferrant, A., Deeren, D., Van de Velde, A., Wynendaele, W., De Bock, R., Efira, A., Breems, D. D., Deweweire, A., Geldhof, K., Pluymers, W., Harrington, A., MacDonald, K., Abraham, I., & Ravoet, C. (2014). Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes. Leukemia research, 38(5), 557-563. doi:10.1016/j.leukres.2014.02.003


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/183259

Delforge, M., Selleslag, D., Beguin, Y., Triffet, A., Mineur, P., Theunissen, K., Graux, C., André, M., Trullemans, F., Boulet, D., Van Eygen, K., Noens, L., Van Steenweghen, S., Lemmens, J., Pierre, P., D'hondt, R., Ferrant, A., Deeren, D., Van de Velde, A., Wynendaele, W., De Bock, R., Efira, A., Breems, D. D., Deweweire, A., Geldhof, K., Pluymers, W., Harrington, A., MacDonald, K., Abraham, I., & Ravoet, C. (2014). Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes. Leukemia research, 38(5), 557-563. doi:10.1016/j.leukres.2014.02.003